EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy

Jiaao Sun, Liyan Yu, Xueling Qu, Tao Huang

Frontiers in Pharmacology · 12.05.2023 · 14

DOI: 10.3389/fphar.2023.1184794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.05.2023. Verfasst von Jiaao Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First Affiliated Hospital, Dalian Medical University, Dalian, China. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peroxisome proliferator-activated receptors (PPARs) have been extensively studied for over 3 decades and consist of three isotypes, including PPARα, γ, and β/δ, that were originally considered key metabolic regulators controlling energy homeostasis in the body. Cancer has become a leading cause of human mortality worldwide, and the role of peroxisome proliferator-activated receptors in cancer is increasingly being investigated, especially the deep molecular mechanisms and effective cancer therapies. Peroxisome proliferator-activated receptors are an important class of lipid sensors and are involved in the regulation of multiple metabolic pathways and cell fate. They can regulate cancer progression in different tissues by activating endogenous or synthetic compounds. This review emphasizes the significance and knowledge of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anti-cancer treatment by summarizing recent research on peroxisome proliferator-activated receptors. In general, peroxisome proliferator-activated receptors either promote or suppress cancer in different types of tumor microenvironments. The emergence of this difference depends on various factors, including peroxisome proliferator-activated receptor type, cancer type, and tumor stage. Simultaneously, the effect of anti-cancer therapy based on drug-targeted PPARs differs or even opposes among the three peroxisome proliferator-activated receptor homotypes and different cancer types. Therefore, the current status and challenges of the use of peroxisome proliferator-activated receptors agonists and antagonists in cancer treatment are further explored in this review.

Schlagwörter

Stichwörter der Autor:innen

PPARsanti-cancer therapycancermetabolic reprogrammingtumor microenvironment

Autor:innen und Institutionen

  • Department of Urology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Department of Respiratory and Critical Care Medicine, First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, China.
  • Dalian Women and Children's Medical Center(Group), Dalian, Liaoning, China.

Zitieren

APA

Sun, J., Yu, L., Qu, X., & Huang, T. (2023). The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1184794

Vancouver

Sun J, Yu L, Qu X, Huang T. The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1184794

BibTeX
@article{Sun2023,
  author = {Sun, Jiaao and Yu, Liyan and Qu, Xueling and Huang, Tao},
  title = {The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1184794}
}
Kostenlos starten →